slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 20,461-20,490
Pages 885
Rows per page 30
Arc
20,461-20,490 of 26,550
66
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
67
The table shows financial results for the six months ended 30 June 2022 vs 2021. Expenses are shown in parentheses indicating negative values.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
68
The slide explains the impact of non-recurring business combination costs on the operating loss.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
69
The slide reconciles operating loss to cash expended from underlying operating activities and shows the movement in cash balance.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
70
The slide uses a hub-and-spoke diagram to link the company to five specific capital allocation priorities.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
71
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
72
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
73
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
74
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
04
The slide uses a timeline-style visualization for clinical trial phases.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
05
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
06
The slide uses a structured table format to summarize key product attributes.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a causal chain/process flow to show how the drug combination interrupts the pathway from stimulus to cancer growth.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a table structure to map clinical strategy to market opportunity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
09
The slide uses a table format to link clinical trial progress with market opportunity (patient numbers) and medical need.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
01
Exhibit 99.1 indicates this is likely a public filing or investor relations document.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
02
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
03
Slide provides a snapshot of product approval, financial performance, and market opportunity.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SetupLoop · Golden Circle1 hit
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectively, creating a market need.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
06
The slide uses a biological pathway diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide outlines a randomized controlled trial design for Myelofibrosis treatment.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
10
The slide uses a process flow diagram to represent clinical trial methodology.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
14
Data presented as median values with interquartile ranges (IQR).CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
18
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
19
Slide emphasizes clinical validation and market positioning via guideline inclusion.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
20
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
05
The slide uses a list-based layout to present key metrics with corresponding descriptions.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · KPI Overview1 hit
08
Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · Key Takeaways1 hit
11
Includes scientific citation at the bottom.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit